REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Clover Biopharmaceuticals, Limited (三叶草生物制药有限公司) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Clover Biopharmaceuticals, Limited Profile Updated: October 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Clover Biopharmaceuticals, Limited focuses on developing new vaccines and biotherapy products for COVID-19, malignant ascites and ankylosing spondylitis. The company was founded in 2018 and headquartered in Chengdu City, China.

Headquarters
49F, Park Place, 1598-1601 West Nanjing Road, Jing'An District
Shanghai; Shanghai;

Contact Details: Purchase the Clover Biopharmaceuticals, Limited (三叶草生物制药有限公司) report to view the information.

Website: http://www.cloverbiopharma.com

Basic Information
Total Employees:
Purchase the Clover Biopharmaceuticals, Limited (三叶草生物制药有限公司) report to view the information.
Outstanding Shares:
Purchase the Clover Biopharmaceuticals, Limited (三叶草生物制药有限公司) report to view the information.
Registered Capital:
Purchase the Clover Biopharmaceuticals, Limited (三叶草生物制药有限公司) report to view the information.
Financial Auditors:
Purchase the Clover Biopharmaceuticals, Limited (三叶草生物制药有限公司) report to view the information.
Incorporation Date:
October 31, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
7.03%
Purchase this report to view the information.
5.4%
Purchase this report to view the information.
5.12%
Purchase this report to view the information.
3.79%
Purchase this report to view the information.
Subsidiaries
Clover Biopharmaceuticals (Hong Kong) Co., Limited
100%
Clover Biopharmaceuticals Aus Pty Ltd. (Australia)
100%
Company Performance
Financial values in the chart are available after Clover Biopharmaceuticals, Limited (三叶草生物制药有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
N/A
Total operating revenue
-61.72%▼
Operating profit (EBIT)
-0.59%▼
EBITDA
-8.66%▼
Net Profit (Loss) for the Period
-4.94%▼
Total assets
-66.91%▼
Total equity
-105.05%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-5.48%▼
Debt to Equity Ratio
26.99%▲
Quick Ratio
-0.19%▼
Cash Ratio
0%

Similar companies

China Resources Pharmaceutical Group Ltd
 
Fosun International Limited
CSPC Pharmaceutical Group Limited
 
Sino Biopharmaceutical Limited
China Traditional Chinese Medicine Holdings Co. Limited
 
United Laboratories International Holdings Limited
Antengene Corporation Limited
 
MediNet Group Limited (Hong Kong) (医汇集团有限公司 (香港))
Sanai Health Industry Group Company Limited
 
Pa Shun International Holdings Limited
New Ray Medicine International Holding Limited
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo